On August 13, 2020, at 07:00 CEST, Calliditas Therapeutics published its interim report for the second quarter 2020.
Calliditas Therapeutics AB
Kungsbron 1, C8
SE-111 22 Stockholm
Company number: 556659-9766
© Calliditas Therapeutics AB 2020